FDA
approval
· 2014-09-15
FDA Approved: CLINIMIX E — Supplemental Application (Baxter Healthcare Company)
Summary
FDA approved a supplemental application for Clinimix E, Baxter's intravenous parenteral nutrition product, approving its updated formulation components.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)